Galina Gabriely,
Instructor, Department of Neurology
Galina Gabriely is researcher at the Brigham and Women’s Hospital and Harvard Medical School. She was trained as a Molecular Biologist in the area of intracellular transport and obtained her Ph.D. at the Weizmann Institute of Science in Israel. Then, she studied the functions of microRNAs in the most malignant brain tumor and currently incurable cancer, glioblastoma. In her first study, she identified the mechanisms of function of miR-21 and miR-10b in glioma pathogenesis. In 2011, Dr. Gabriely joined the lab of Dr. Weiner to investigate the role of immune suppression in gliomagenesis. With recent successes in employing immunotherapeutic antibodies in clinics, she decided to explore the therapeutic effects and mechanism of function of anti-latency-associated peptide (LAP) antibody against glioblastoma. Currently, Dr. Gabriely is investigating the anti-tumorigenic role of anti-LAP antibody in different cancer models. She is also interested in examining the synergistic effects of anti-LAP when combined with existing treatment modalities.
|
|
|
